The United States Food and Drug Administration (USFDA) has issued a warning letter to Hyderabad-based online retailer ...
The U.S. FDA has sent a new batch of warning letters to telehealth firms that allegedly made false and misleading claims about low-cost compounded versions of GLP-1 drugs, the popular class of ...
After debuting on the public markets with $256.3 million and raking in an additional $472 million, Veradermics has emerged as one of biotech’s biggest post-IPO standouts. CEO Reid Waldman credits the ...
How new review policies, the use of AI and other recent FDA changes are being impacted by high turnover at the top.
As the World Cup has captured the attention of viewers around the globe, so has the Food and Drug Administration (FDA) when it comes to ...
On June 22, 2026, the U.S. Department of Health and Human Services (HHS) announced the launch of Operation TrialBlazer, a coordinated effort ...
Cemdisiran, a potential new drug for the treatment of generalized myasthenia gravis, has been accepted for priority review by ...
It isn't approved by the FDA, but we found an experimental weight-loss drug called retatrutide for sale at a local ...
The Food and Drug Administration is meeting next month to consider easing restrictions on several peptides, a group of ...
The US Food and Drug Administration (FDA) revised its compliance program guide (CPG) for preapproval inspections (PAIs) for new drugs. This update emphasizes a risk-based approach to making decisions ...
Gore & Associates announced that the FDA approved updated labeling for the Gore Excluder abdominal aortic aneurysm (AAA) ...
Welcome to another installment of This Week at FDA, your weekly source for updates – big and small – on FDA, drug and medical device regulation, and what we’re reading from around the web. This week, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results